Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Raw Materials (2016 - 2025)

Historic Raw Materials for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $96.2 million.

  • Bio-Techne's Raw Materials rose 1458.19% to $96.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $96.2 million, marking a year-over-year increase of 1458.19%. This contributed to the annual value of $89.1 million for FY2025, which is 1222.39% up from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Raw Materials is $96.2 million, which was up 1458.19% from $94.0 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Raw Materials peaked at $96.2 million during Q4 2025, and registered a low of $51.7 million during Q1 2021.
  • In the last 5 years, Bio-Techne's Raw Materials had a median value of $82.5 million in 2023 and averaged $78.2 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 4391.43% in 2022, then plummeted by 745.01% in 2024.
  • Quarter analysis of 5 years shows Bio-Techne's Raw Materials stood at $61.6 million in 2021, then skyrocketed by 37.54% to $84.8 million in 2022, then fell by 1.78% to $83.2 million in 2023, then increased by 0.86% to $84.0 million in 2024, then grew by 14.58% to $96.2 million in 2025.
  • Its last three reported values are $96.2 million in Q4 2025, $94.0 million for Q3 2025, and $89.1 million during Q2 2025.